QualityStocksNewsBreaks Archives - Page 1342 of 1563

ThursdayDec 06, 2018 12:30 pm

QualityStocksNewsBreaks – Cyberfort Software, Inc. (CYBF) Utilizes Various Software Protection Tools to Fight Potential Cyber Attacks

Cybersecurity technology company Cyberfort Software (OTC: CYBF) is leveraging its artificial intelligence (“AI”) content filtering and other software protection tools to combat increasingly dangerous internet activities. A recent article discussing the company reads, “Cyberfort Software’s mission is to adapt AI content filtering practices and software protection tools to the threat that hackers pose, strengthening the online security of companies and other users through multi-platform content filtering and ad blocking technology. The company specializes in acquiring and creating technology that provides cyber security, protects users’ privacy and blocks advertisements. … CYBF’s recent acquisition of content filter developer Vivio furthered its aim…

ThursdayDec 06, 2018 11:13 am

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Pursues Licensing to Begin Substantial Cultivation Operations in Central California

Cannabis Strategic Ventures (OTC: NUGS) this morning announced its intention to pursue twenty cannabis licenses from the California Bureau of Cannabis Control that will lead to the development of a substantial 250,000 square feet of turnkey greenhouse cannabis growth operation in the central part of the state. The targeted location is equipped with critical infrastructure, including irrigation and storage facilities, that will enable Cannabis Strategic Ventures to immediately begin operations upon receipt of permitting. “This is a significant event for our Company and its investors,” Cannabis Strategic CEO Simon Yu stated in the news release. “At approximately one quarter million…

ThursdayDec 06, 2018 10:42 am

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Eyeing Opportunity Amid California’s Expected Mass ‘Green Lighting’ of Annual Cannabis Cultivation Applications

Hydroponics supply company Sugarmade (OTCQB: SGMD) today provided comments on its expected revenue growth in hydroponic related supplies amidst the rapidly-changing California cannabis cultivation licensing environment. Sugarmade expects accelerated revenue growth as a result of the state’s projected mass "Green Lighting" of annual cultivation permits that it projects will spur purchase of cultivation supplies by large grow operations. "Our customers, especially those in Santa Barbara, Monterey and Humbolt counties, the three most prolific cultivation areas in California, are indicting to us they too are expecting the permitting process to break free shortly and they are thus informing us of their…

ThursdayDec 06, 2018 10:32 am

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Presents Initial Data from Bria-IMT Combination Study at Major Breast Cancer Conference

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatment options for cancer, this morning announced the presentation of initial safety data from the combination study of its lead candidate, Bria-IMT, with pembrolizumab [KEYTRUDA®; manufactured by Merck & Co., Inc. (NYSE: MRK)] and confirmation of positive proof of concept data on Bria-IMT for advanced breast cancer at the 2018 San Antonio Breast Cancer Symposium. “I am very excited about our data continuing to show robust biological activity of Bria-IMT™ in advanced breast cancer,” Dr. Bill Williams, president and CEO of BriaCell, stated in the news release.…

ThursdayDec 06, 2018 10:13 am

QualityStocksNewsBreaks – Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Enters Strategic Partnership with Khalifa Kush Enterprises

Supreme Cannabis Company (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced its entry into an exclusive consulting services agreement with Khalifa Kush Enterprises Canada ULC ("KKE Canada") an affiliate of Khalifa Kush Enterprises, LLC ("KKE USA", and together with KKE Canada "KKE"). Under the agreement, KKE will provide cannabis related consulting services to Supreme, which will, in turn, be the exclusive producer of KKE branded products in Canada and, subject to approval, other international markets outside of the U.S. This will include development of a strain based on KKE's flagship "Khalifa Kush,” and development and commercialization of a product lineup…

ThursdayDec 06, 2018 9:53 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) to Host Conference Call, Provide Business Update on December 12, 2018

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced that President and CEO Nader Pourhassan, Ph.D., and Chief Medical Officer Richard Pestell, M.D., Ph.D., F.A.C.P., M.B.A., will host an investment community conference call on Wednesday, December 12, at 4:00 p.m. ET. To access the call, interested parties should dial 877-407-2986 (U.S. and Canada) or 201-378-4916 (international). A live audio webcast of the call may also be accessed via CytoDyn’s corporate website at www.CytoDyn.com under the Investors section, and it will be archived for 60 days following the conclusion of the call. Web participants are encouraged to visit the website 15…

ThursdayDec 06, 2018 9:51 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances Final Tranche for Buildout of Refined Resin Facility

Royalty company for the U.S. licensed medical cannabis industry FinCanna Capital (CSE: CALI) (OTCQB: FNNZF) today announced its advancement of $750,000 to investee company Refined Resin Technologies Inc., an Oakland, California-based cannabinoid research and extraction company. This is FinCanna’s third and final tranche of its $3 million capital commitment to Refined Resin to fund the build out and operationalization of its 6,000 square foot, state-of-the-art medical cannabis extraction laboratory. “We are very pleased to see the company hitting key milestones as it moves towards full commercialization,” FinCanna Capital President and CEO Andriyko Herchak stated in the news release. “With its…

ThursdayDec 06, 2018 9:23 am

QualityStocksNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) Reports Three Executives Are Set to Speak at Vancouver O’Cannabiz 2018

Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) this morning announced upcoming speaking engagements for the company and a portfolio client, Mary’s Tea, at the O’Cannabiz Conference and Expo: Vancouver taking place December 10-11, 2018. Virginia Vidal, CEO of Mary’s Tea, will serve as a head panelist at the expo and will be discussing edibles, infused foods and infused beverages. Redfund Capital Director Amanda De Freitas and CEO and Director Meris Kott will be discussing topics including the future of cannabis currency and the capacity to track supply chains, sales and transactions digitally. “O’Cannabiz is more about medical cannabis than…

TuesdayDec 04, 2018 3:22 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd.’s (TSX: TGOD) (OTCQX: TGODF) Recent Supply Agreement Provides Opening to Canadian Provincial Cannabis and Liquor Boards

Cannabis-focused research and development (“R&D”) company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) recently announced that it will serve as the exclusive certified organic producer for Velvet Management Inc., securing a solid entry point with provincial cannabis and liquor boards across Canada. A recent article discussing the company reads, “Under the partnership, Velvet will distribute TGOD’s premium organic cannabis across all recreational adult use markets in Canada through provincial liquor and cannabis boards. Velvet is a new company created by Philippe Dandurand Wines, the largest wine distributor in Canada. Dandurand established Velvet Management Inc. to focus on the…

TuesdayDec 04, 2018 2:46 pm

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Clinical Program Throughout 2018

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company focusing its efforts on immuno-oncology through the development of targeted, safe treatment options for cancer, has been working diligently to advance its clinical program. A recent article discussing the company reads, “The company attained crucial safety and efficacy data via its clinical trials, and it also achieved proof of concept. The phase I/IIa study of its proof of concept clinical trial in advanced breast cancer achieved sustained tumor shrinkage at various sites in several patients. These results confirm the data collected through two previous trials, demonstrating the promising effect of the…

Site Search

Company Search

Category: QualityStocksNewsBreaks